{"entity":{"type":"insider","cik":"0001826129","url":"/insider/0001826129","json_url":"/insider/0001826129.json","name":"Shakil Ian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":9,"first":"2024-04-01","last":"2024-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Shakil Ian","source":"filing","n_filings":9,"first_seen":"2024-04-01","last_seen":"2024-05-17"}],"transactions":[{"id":2321030,"accession":"0001213900-24-044878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-044878","line_url":"/filing/0001213900-24-044878#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1387.0,"shares_display":"1,387","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":1650.53,"total_display":"1,650.53","total_whole":"1,651","shares_owned_after":5363.0,"shares_owned_after_display":"5,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":2179030,"accession":"0001213900-24-033562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-033562","line_url":"/filing/0001213900-24-033562#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","total_whole":"1,900","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-15","filed_date":"2024-04-16","scope":"insider"},{"id":2916920,"accession":"0001213900-24-033121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-033121","line_url":"/filing/0001213900-24-033121#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19544.0,"shares_display":"19,544","price_per_share":3.8165,"price_display":"3.82","price_state":"stated","total_value":74589.676,"total_display":"74,589.68","total_whole":"74,590","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-12","filed_date":"2024-04-15","scope":"insider"},{"id":2739384,"accession":"0001213900-24-032295","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001213900-24-032295","line_url":"/filing/0001213900-24-032295#line-7","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24778.0,"shares_display":"24,778","price_per_share":3.934,"price_display":"3.93","price_state":"stated","total_value":97476.652,"total_display":"97,476.65","total_whole":"97,477","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-11","scope":"insider"},{"id":2739375,"accession":"0001213900-24-032295","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-24-032295","line_url":"/filing/0001213900-24-032295#line-5","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36467.0,"shares_display":"36,467","price_per_share":3.8744,"price_display":"3.87","price_state":"stated","total_value":141287.7448,"total_display":"141,287.74","total_whole":"141,288","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-04-11","scope":"insider"},{"id":2739366,"accession":"0001213900-24-032295","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-032295","line_url":"/filing/0001213900-24-032295#line-3","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31542.0,"shares_display":"31,542","price_per_share":4.138,"price_display":"4.14","price_state":"stated","total_value":130520.796,"total_display":"130,520.80","total_whole":"130,521","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-11","scope":"insider"},{"id":2852549,"accession":"0001213900-24-031700","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-24-031700","line_url":"/filing/0001213900-24-031700","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37780.0,"shares_display":"37,780","price_per_share":3.9695,"price_display":"3.97","price_state":"stated","total_value":149967.71,"total_display":"149,967.71","total_whole":"149,968","shares_owned_after":12217.0,"shares_owned_after_display":"12,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-09","scope":"insider","n_lines":2},{"id":2852528,"accession":"0001213900-24-031700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-031700","line_url":"/filing/0001213900-24-031700#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51387.0,"shares_display":"51,387","price_per_share":4.0328,"price_display":"4.03","price_state":"stated","total_value":207233.4936,"total_display":"207,233.49","total_whole":"207,233","shares_owned_after":12217.0,"shares_owned_after_display":"12,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-05","filed_date":"2024-04-09","scope":"insider"},{"id":2888737,"accession":"0001213900-24-030585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-030585","line_url":"/filing/0001213900-24-030585#line-2","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64055.0,"shares_display":"64,055","price_per_share":4.1504,"price_display":"4.15","price_state":"stated","total_value":265853.872,"total_display":"265,853.87","total_whole":"265,854","shares_owned_after":31610.0,"shares_owned_after_display":"31,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-04","scope":"insider"},{"id":2888732,"accession":"0001213900-24-030585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-030585","line_url":"/filing/0001213900-24-030585#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45906.0,"shares_display":"45,906","price_per_share":4.1084,"price_display":"4.11","price_state":"stated","total_value":188600.2104,"total_display":"188,600.21","total_whole":"188,600","shares_owned_after":95665.0,"shares_owned_after_display":"95,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-04","scope":"insider"},{"id":2383094,"accession":"0001213900-24-030037","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-24-030037","line_url":"/filing/0001213900-24-030037#line-4","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38463.0,"shares_display":"38,463","price_per_share":3.8927,"price_display":"3.89","price_state":"stated","total_value":149724.9201,"total_display":"149,724.92","total_whole":"149,725","shares_owned_after":141571.0,"shares_owned_after_display":"141,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":2383092,"accession":"0001213900-24-030037","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-030037","line_url":"/filing/0001213900-24-030037","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58978.0,"shares_display":"58,978","price_per_share":3.9062625182271353,"price_display":"3.91","price_state":"stated","total_value":230383.5508,"total_display":"230,383.55","total_whole":"230,384","shares_owned_after":187666.0,"shares_owned_after_display":"187,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":2},{"id":9273016,"accession":"0001213900-24-031697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-031697","line_url":"/filing/0001213900-24-031697#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31994.0,"shares_display":"31,994","price_per_share":4.0586,"price_display":"4.06","price_state":"stated","total_value":129850.8484,"total_display":"129,850.85","total_whole":"129,851","shares_owned_after":219660.0,"shares_owned_after_display":"219,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-09","scope":"insider"},{"id":2992872,"accession":"0001213900-24-029014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-029014","line_url":"/filing/0001213900-24-029014#line-1","is_derivative":false,"issuer_cik":"0001769804","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001769804","owner_cik":"0001826129","owner_name":"Shakil Ian","owner_display_name":"Shakil Ian","owner_url":"/insider/0001826129","role":"Director, Officer (CHIEF STRATEGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF STRATEGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31994.0,"shares_display":"31,994","price_per_share":4.0586,"price_display":"4.06","price_state":"stated","total_value":129850.8484,"total_display":"129,850.85","total_whole":"129,851","shares_owned_after":187666.0,"shares_owned_after_display":"187,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001769804","name":"Augmedix, Inc.","url":"/issuer/0001769804","role":"Director, Officer (CHIEF STRATEGY OFFICER)","n_filings":9,"first_seen":"2024-04-01","last_seen":"2024-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001826129","retrieved_at":"2026-08-26T04:53:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}